Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01923506 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer After Undergoing Surgery

StatusActive, Not Recruiting
PhasePhase 1
Started2013-11-25
View on ClinicalTrials.gov ↗
This phase I trial studies the side effects and best dose of stereotactic body radiation therapy in treating patients with prostate cancer after undergoing surgery. Stereotactic body radiation therapy may be able to send x-rays directly to the tumor and cause less damage to normal tissue.

Amendment history 2 changes detected by DataLookout

2026-09-02
Primary completion pushed: 2026-07-28 → 2027-06-28
2026-09-02
Completion pushed: 2026-07-28 → 2027-06-28
Trial Details
NCT Number NCT01923506
Lead Sponsor City of Hope Medical Center
Collaborators: National Cancer Institute (NCI)
Conditions Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer
Enrollment 26 participants
Start Date 2013-11-25
Primary Completion 2027-06-28 (estimated)
Study Completion 2027-06-28 (estimated)
Updated on ClinicalTrials.gov 2026-09-01